We are live on
!
Find out more
IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
28 hedge funds and large institutions have $3.41M invested in ImmunoCellular Therapeutics, Ltd. in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 28 → 28 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
28% less capital invested
Capital invested by funds: $4.76M → $3.41M (-$1.35M)
Holders
28
Holders Change
–
Holders Change %
0%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$113K |
| 2 |
Renaissance Technologies
New York
|
+$93.3K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$8.12K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.35K |
| 5 |
LPL Financial
San Diego,
California
|
+$4.54K |